Kellner Capital, LLC’s Alexion Pharmaceuticals Inc Position
Does Kellner Capital, LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 130.5K shares worth $24M in Q2 2021; the fund’s latest 13F (Q4 2023) no longer reports it.
Position Value
$24M
Q2 2021
Shares
130.5K
% of Portfolio
+7.35%
Quarters Held
3
position exited
Position History ALXN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kellner Capital, LLC’s full portfolio or all institutional holders of ALXN.